Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 01 Jul 2025 – 20 Aug 2026, limited by Motilal Oswal BSE 1000 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Motilal Oswal BSE 1000 Index Fund | Nifty 500 |
|---|---|---|
| 01 Jul 2025 | ₹100.00 | ₹100.00 |
| 05 Aug 2025 | ₹96.72 | ₹96.54 |
| 08 Sep 2025 | ₹97.14 | ₹96.88 |
| 13 Oct 2025 | ₹98.66 | ₹98.64 |
| 16 Nov 2025 | ₹100.78 | ₹100.94 |
| 21 Dec 2025 | ₹99.87 | ₹100.26 |
| 25 Jan 2026 | ₹95.49 | ₹96.15 |
| 28 Feb 2026 | ₹97.46 | ₹98.10 |
| 04 Apr 2026 | ₹88.18 | ₹88.66 |
| 08 May 2026 | ₹97.51 | ₹97.88 |
| 12 Jun 2026 | ₹95.45 | ₹95.70 |
| 16 Jul 2026 | ₹98.41 | ₹98.38 |
| 20 Aug 2026 | ₹99.95 | ₹99.57 |
| Metric | Motilal Oswal · Regular NAV ₹10.14 Very High risk ★★☆☆☆ 1Y | Category median Index Funds · 366 funds |
|---|---|---|
| +1.84% | +5.43% | |
| — | +8.41% | |
| — | +8.95% | |
| — | +11.28% | |
| -0.04% | +7.40% | |
| +4.01% | — | |
| — | +11.37% | |
| — | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 13.48% | 13.88% | |
| -0.34 | 0.25 | |
| -0.47 | 0.35 | |
| -15.07% | -16.66% | |
| Nifty 500 | — | |
| — | +0.30% | |
| — | 1.00 | |
| — | 101.3% | |
| — | 98.8% | |
| 1.12% | 0.96% | |
| ₹60.25Cr | ₹182.17Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 13% | 35% | |
| Swapnil Mayekar · 1.2y | — | |
| 01 Jul 2025 | — | |
| 1001 | — | |
| 28.3% | — | |
| 0.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.